Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase
Year: 2012
Type: article
Abstract: Tolerance to self-antigens present in apoptotic cells is critical to maintain immune-homeostasis and prevent systemic autoimmunity. However, mechanisms that sustain self-tolerance are poorly understood. Here we show that systemic administration of apoptotic cells to mice induced splenic expression of the tryptophan catabolizing enzyme indoleamine 2,3-dioxygenase (IDO). IDO expression was confined to the splenic marginal zone and was abrogated by depletion of CD169(+) cells. Pharmacologic inhibition of IDO skewed the immune response to apoptotic cells, resulting in increased proinflammatory cytokine production and increased effector T-cell responses toward apoptotic cell-associated antigens. Presymptomatic lupus-prone MRL(lpr/lpr) mice exhibited abnormal elevated IDO expression in the marginal zone and red pulp and inhibition of IDO markedly accelerated disease progression. Moreover, chronic exposure of IDO-deficient mice to apoptotic cells induced a lupus-like disease with serum autoreactivity to double-stranded DNA associated with renal pathology and increased mortality. Thus, IDO limits innate and adaptive immunity to apoptotic self-antigens and IDO-mediated regulation inhibits inflammatory pathology caused by systemic autoimmune disease.
Institutions: RIKEN, Karolinska Institutet
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Awards: Role of IDO in malignancy, The role of indoleamine 2-3 dioxygenase in marginal zone-mediated tolerance, IDO dependent T cell suppression, The role of CD169 macrophages in anti-tumor immunity induced by dead tumor cells, Reprogramming the TME for immunogenic antigen-presentation, IDO-mediated immune regulation in established tumors, T cell regulation by IDO-competent plasmacytoid dendritic cells
OpenAlex ID: W2053485564
